Art. 1 Aim and scope
1 This Ordinance regulates: - a.
- the determination and assessment of dangers and risks that substances and preparations may pose to human life and health and to the environment;
- b.
- the conditions under which substances and preparations that may endanger people or the environment are placed on the market;
- c.
- the handling of substances and preparations that may endanger people or the environment;
- d.
- the way in which data relating to substances and preparations is processed by the enforcement authorities.
2 This Ordinance applies to biocidal products and the active substances contained therein, and to plant protection products and the active substances and co-formulants contained therein, insofar as they are referred to in the Ordinance of 18 May 2005 on Biocidal Products7 or the Ordinance of 12 May 20108 on Plant Protection Products. 3 This Ordinance applies to radioactive substances and preparations, excluding effects attributable to the radioactive nature of these substances and preparations. 4 Only Articles 5–7 and 81 apply to cosmetic products within the meaning of Article 53 paragraph 1 of the Ordinance of 16 December 20169 on Foodstuffs and Utility Articlesin the form of finished products intended for private or professional users, and only with regard to environmental protection and to classification or assessment in relation to risks to the environment.10 5 This Ordinance does not apply to: - a.
- the transport of substances and preparations by road, rail, water, air or pipelines, with the exception of Article 10 paragraph 1 letter b;
- b.
- the transit of substances and preparations under customs supervision, provided that this does not involve any processing or transformation;
- c.
- substances and preparations in the form of finished products ready for supply to private and professional users that fall into the following categories:11
- 1.12
- foodstuffs as defined by Article 4 of the Foodstuffs Act of 20 June 201413 (FoodA),
- 2.
- medicinal products as defined by Article 4 paragraph 1 letter a and medical devices as defined by Article 4 paragraph 1 letter b of the Therapeutic Products Act of 15 December 200014,
- 3.
- animal feedingstuffs as defined by Article 3 paragraph 1 of the Feedstuffs Ordinance of 26 October 201115;
- d.
- weapons and ammunition as defined by Article 4 paragraphs 1 and 5 of the Weapons Act of 20 June 199716;
- e.
- substances, preparations and objects which are waste according to Article 7 paragraph 6 of the EPA.
6 Articles 57, 62 and 67 apply to imported substances and preparations that are simply relabelled and then exported without alteration.17 7 Dangerous substances and preparations that are exported are also governed by the PIC Ordinance of 10 November 200418.19
|
Art. 2 Definitions and applicable legislation
1 By way of clarification of the definitions given in the Chemicals Act, in this Ordinance: - a.
- substancemeans a chemical element and its compounds in the natural state or obtained by any manufacturing process, including any additive necessary to preserve its stability and any impurity deriving from the process used, but excluding any solvent which may be separated without affecting the stability of the substance or changing its composition;
- b.
- manufacturer means:
- 1.
- any natural or legal person domiciled in Switzerland or with a registered office or branch in Switzerland, who manufactures, extracts or imports substances, preparations or objects in a professional or commercial capacity, and
- 2.20
- any person who obtains substances, preparations or objects in Switzerland and supplies them on a commercial basis, without altering their composition:
- –
- under his own name, without specifying the name of the original manufacturer,
- –
- under his own trade name,
- –
- in packaging other than that provided by the original manufacturer,
- –
- for a different intended use, or
- –
- at a location where the labelling in accordance with Article 10 paragraph 3 letter b has not been applied in the official language by the original manufacturer,
- 3.21
- a person is deemed to be the sole manufacturer if he arranges for the manufacture of a substance, preparation or object in Switzerland by a third party, and if he is domiciled or has a registered office or branch in Switzerland; if he has neither his domicile, a registered office or branch in Switzerland, the third party is the sole manufacturer.
2 In addition, in this Ordinance: - a.
- professional user means:
- 1.
- any natural or legal person who obtains substances, preparations or objects in Switzerland for use in professional activities,
- 2.
- also deemed to be a professional user is:
- –
- any natural or legal personwho obtains substances, preparations or objects in Switzerland for use in the course of training or for research purposes,
- –
- any legal personwho obtains substances, preparations or objects in Switzerland for use in charitable activities;
- b.
- private user means any natural personwho obtains or uses substances, preparations or objects for non-professional purposes;
- c.
- trader means any natural or legal person who obtains substances, preparations or objects in Switzerland and supplies them unchanged on a commercial basis;
- d.
- exclusive representative means any natural or legal person that is authorised by a manufacturer whose domicile or registered office is located abroad to notify a substance in Switzerland and represents several importers designated by that manufacturer;
- e.
- object means an article, consisting of one or more substances or preparations, which during production is given a special shape, surface or design which determines its end use function to a greater degree than does its chemical composition;
- f.22
- existing substance means the substance that is registered in accordance with Article 5 of Regulation (EC) No 1907/2006 (REACH Regulation)23, with the exception of substances that:
- 1.24
- are placed on the market in larger quantities than those registered in the European Economic Area (EEA), or
- 2.
- are registered solely as intermediates, unless they are monomers;
- g.
- polymermeans a substance consisting of molecules characterised by the sequence of one or more types of monomer units and comprising:
- 1.
- a simple weight majority of molecules containing at least three monomer units which are covalently bound to at least one other monomer unit or other reactant, and
- 2.
- less than a simple weight majority of molecules of the same molecular weight; these molecules must be distributed over a range of molecular weights wherein differences in the molecular weight are primarily attributable to differences in the number of monomer units;
- h.
- monomer means a substance which is capable of forming covalent bonds with a sequence of additional like or unlike molecules under the conditions of the relevant polymer-forming reaction used for the particular process;
- i.
- monomer unitmeans the reacted form of a monomer substance in a polymer;
- j.
- intermediate means a substance manufactured and used solely for chemical processing during which it is transformed into one or more other substances;
- k.
- secondary product means any substance formed by chemical or biochemical transformation during the storage, use or disposal of a substance or preparation;
- l.
- scientific research and development means any scientific experimentation, analysis or chemical research carried out under controlled conditions and involving quantities of less than 1 tonne per year;
- m.
- product and process-orientated research and developmentmeans any scientific development related to product development or the further development of a substance on its own, in preparations or in objects in the course of which pilot plant or production trials are used to define the production process or test the fields of application of the substance;
- n.
- robust study summary means a detailed summary of the objectives, methods, results and conclusions of a full study report providing sufficient information to make an independent assessment of the study, minimising the need to consult the full study report;
- o.
- exposure scenario means the set of conditions, including operational conditions and risk management measures, that describe how the substance is manufactured or used during its life-cycle and how the manufacturer controls, or recommends customers to control, exposures of humans and the environment. These exposure scenarios may cover one specific process or use or several processes or uses as appropriate;
- p.
- hazard class means the nature of the physical, health or environmental hazard;
- q.
- nanomaterial means a material containing particles in an unbound state or as an aggregate or as an agglomerate, where one or more external dimensions is in the size range 1–100 nm, or a material where the specific surface area by volume is greater than 60 m2/cm3. A material is only considered to be a nanomaterial if it is deliberately produced to utilise the properties arising from the defined external dimensions of the particles it contains, or from the defined surface area by volume of the material. Fullerenes, graphene flakes and single-wall carbon nanotubes with one or more external dimensions below 1 nm are considered to be nanomaterials;
- r.25
- colorants means substances and preparations that primarily contain colouring agents, colour pigments and effect-producing pigments which are added solely for the purpose of colouring or producing effects.
3 Any other terms which are used in various senses in the legislation underlying this Ordinance are used here as defined in the Chemicals Act. 4 The equivalence of expressions between the REACH Regulation, Regulation (EC) No 1272/2008 (CLP Regulation)26 and Directive 75/324/EEC27, and this Ordinance as specified in Annex 1 number 1 applies.28 5 If in this Ordinance reference is made to provisions of the REACH Regulation, the CLP Regulation or Directive 75/324/EECwhich in turn refer to other provisions of these acts, these other provisions also apply; the applicable version of the act in question is that specified in the footnote to paragraph 2 letter f or, as applicable, paragraph 4 or, in the case of references to annexes to the CLP Regulation or the REACH Regulation, the version specified in Annex 2 number 1 or, as applicable, Annex 4 number 3. An exception are provisions referred to in provisions of the REACH Regulation and the CLP Regulation, as specified in Annex 1 number 2; here, the provisions of the Swiss legislation listed in Annex 1 number 2 apply instead.29 6 If in this Ordinance reference is made to provisions of the REACH Regulation or the CLP Regulation which in turn refer to other EU legislation, the Swiss legislation specified in Annex 1 number 3 applies instead of the EU legislation. 7 The provisions of the Nagoya Ordinance of 11 December 201530 are reserved with respect to the placing on the market of substances and preparations the development of which is based on the use of genetic resources or on traditional knowledge associated therewith.31 20 Amended by No I of the O of 11 March 2022, in force since 1 May 2022 (AS 2022 220). 21 Amended by No I of the O of 31 Jan. 2018, in force since 1 March 2018 (AS 2018 801). 22 Amended by No I of the O of 11 March 2022, in force since 1 May 2022 (AS 2022 220). 23 Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC, OJ L 396 of 30.12.2006, p. 1; last amended by Regulation (EU) No (EU) 2021/2204, OJ L 446 of 14.12.2021, p. 34. 24 The correction of 5 May 2022 concerns the French text only (AS 2022 273). 25 Inserted by No I of the O of 11 March 2022, in force since 1 May 2022 (AS 2022 220). 26 Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC and amending Regulation (EC) No 1907/2006, OJ L 353 of 31.12.2008, p. 1; last amended by Delegated Regulation (EU) No 2021/1962, OJ L 400 of 12.11.2021, p. 16. 27 Council Directive 75/324/EEC of 20 May 1975 on the approximation of the laws of the Member States relating to aerosol dispensers, OJ L 147 of 9.6.1975, p. 40; last amended by Directive (EU) 2016/2037, OJ L 314 of 22.11.2016, p. 11. 28 Amended by No I of the O of 11 March 2022, in force since 1 May 2022 (AS 2022 220). 29 Amended by Annex No 1 of the O of 15 Nov. 2023, in force since 1 Jan. 2024 (AS 2023 709). 30 SR 451.61 31 Inserted by Annex No 2 of the Nagoya Ordinance of 11 Dec. 2015, in force since 1 Feb. 2016 (AS 2016 277).
|